The status of glycation in protein aggregation

F Taghavi, M Habibi-Rezaei, M Amani… - International Journal of …, 2017 - Elsevier
Protein crucial function and flexibility directly depend on its whole structure which is
determined by the native distribution of structural elements. Any disturbances in a protein …

Advanced glycation end products modulate structure and drug binding properties of albumin

S Awasthi, NA Murugan… - Molecular Pharmaceutics, 2015 - ACS Publications
The extraordinary ligand binding properties of albumin makes it a key player in the
pharmacokinetics and pharmacodynamics of many vital drugs. Albumin is highly susceptible …

Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy

MM Jack, JM Ryals, DE Wright - Diabetologia, 2011 - Springer
Aims/hypothesis Diabetic peripheral neuropathy (DN) is a common complication of diabetes;
however, the mechanisms producing positive or negative symptoms are not well …

Advanced glycation endproducts in horses with insulin-induced laminitis

MA De Laat, MT Kyaw-Tanner, MN Sillence… - Veterinary Immunology …, 2012 - Elsevier
Advanced glycation endproducts (AGEs) have been implicated in the pathogenesis of
cancer, inflammatory conditions and diabetic complications. An interaction of AGEs with their …

Metformin as a geroprotector

S Bulterijs - Rejuvenation research, 2011 - liebertpub.com
Geroprotectors are drugs that decrease the rate of aging and therefore extend life span.
Metformin has been described as a geroprotector, and several studies have shown that …

In vitro glycation of an endothelialized and innervated tissue-engineered skin to screen anti-AGE molecules

S Cadau, S Leoty-Okombi, S Pain, N Bechetoille… - Biomaterials, 2015 - Elsevier
Glycation is one of the major processes responsible for skin aging through induction of the
detrimental formation of advanced glycation end-products (AGEs). We developed an …